Literature DB >> 16238920

Conservative management options for Peyronie's disease.

Gregory S Jack1, Nestor Gonzalez-Cadavid, Jacob Rajfer.   

Abstract

Peyronie's disease is an acquired condition that presents clinically with a palpable induration, a distinct plaque, or a curvature of the erect penis. At times, the erections are painful. Erectile dysfunction (ED) often is associated with Peyronie's disease. The current era of phosphodiesterase therapy for the treatment of ED seems to have increased the number of patients presenting for treatment of Peyronie's disease. During the past decade, significant advances have been made in understanding the pathophysiology of the disease, resulting in numerous nonsurgical therapies proposed for the treatment of Peyronie's disease. These medical treatments can be administered systemically, locally, or intralesionally. Unfortunately, there are few randomized, placebo-controlled trials to evaluate most of these proposed therapies. In evaluating therapies for Peyronie's disease, it must be remembered that the natural disease history includes spontaneous resolution of pain and even a small improvement in penile curvature in some men. This article reviews the natural history, scientific understanding, and nonsurgical treatment options for the mild to moderate Peyronie's deformities. Surgical therapy remains the mainstay of treatment for severe and refractory cases of Peyronie's disease that result in a physical or psychologic dysfunction.

Entities:  

Mesh:

Year:  2005        PMID: 16238920     DOI: 10.1007/s11934-005-0041-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  39 in total

1.  Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report.

Authors:  G Biagiotti; G Cavallini
Journal:  BJU Int       Date:  2001-07       Impact factor: 5.588

2.  Peyronie's disease: results with dermo-jet injection of dexamethasone.

Authors:  C C Winter; R Khanna
Journal:  J Urol       Date:  1975-12       Impact factor: 7.450

3.  A new concept in the treatment of Peyronie's disease.

Authors:  W W SCOTT; P L SCARDINO
Journal:  South Med J       Date:  1948-02       Impact factor: 0.954

4.  Induratio penis plastica Peyronie's disease. Clinical features and etiology.

Authors:  J Byström; C Rubio
Journal:  Scand J Urol Nephrol       Date:  1976

5.  Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction.

Authors:  J P Jarow; F C Lowe
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

6.  Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

Authors:  M Braun; G Wassmer; T Klotz; B Reifenrath; M Mathers; U Engelmann
Journal:  Int J Impot Res       Date:  2000-12       Impact factor: 2.896

7.  Subclinical Peyronie's disease.

Authors:  B H Smith
Journal:  Am J Clin Pathol       Date:  1969-10       Impact factor: 2.493

8.  Etiologic factors in Peyronie's disease.

Authors:  F Hinman
Journal:  Urol Int       Date:  1980       Impact factor: 2.089

9.  Factors associated in the aetiology of peyronie's disease.

Authors:  C P Chilton; W M Castle; C A Westwood; J P Pryor
Journal:  Br J Urol       Date:  1982-12

10.  Is colchicine effective in Peyronie's disease? A pilot study.

Authors:  E Akkus; S Carrier; J Rehman; J Breza; A Kadioglu; T F Lue
Journal:  Urology       Date:  1994-08       Impact factor: 2.649

View more
  3 in total

1.  The Efficacy of Medical Treatment of Peyronie's Disease: Potassium Para-Aminobenzoate Monotherapy vs. Combination Therapy with Tamoxifen, L-Carnitine, and Phosphodiesterase Type 5 Inhibitor.

Authors:  Tae Yong Park; Hyeong Guk Jeong; Jong Jin Park; Ji Yun Chae; Jong Wook Kim; Mi Mi Oh; Hong Seok Park; Je Jong Kim; Du Geon Moon
Journal:  World J Mens Health       Date:  2016-04-30       Impact factor: 5.400

Review 2.  Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.

Authors:  Andrew T Gabrielson; Laith M Alzweri; Wayne Jg Hellstrom
Journal:  World J Mens Health       Date:  2017-09-06       Impact factor: 5.400

Review 3.  Role of collagenase clostridium histolyticum in Peyronie's disease.

Authors:  Taylor C Peak; Gregory C Mitchell; Faysal A Yafi; Wayne J Hellstrom
Journal:  Biologics       Date:  2015-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.